Understanding public perspectives on direct-to-consumer pharmacogenomic testing in the UK: a qualitative study.

Mathieson A, Brunton L, Gillibrand S, Moldovan R, McDermott JH

Open source

DOI
10.1038/s41397-026-00425-1
Published
2026 Jul 25
Container
The pharmacogenomics journal
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41397-026-00425-1,
  title = {Understanding public perspectives on direct-to-consumer pharmacogenomic testing in the UK: a qualitative study.},
  author = {Mathieson A and Brunton L and Gillibrand S and Moldovan R and McDermott JH},
  year = {2026},
  journal = {The pharmacogenomics journal},
  doi = {10.1038/s41397-026-00425-1},
  url = {https://doi.org/10.1038/s41397-026-00425-1}
}

RIS

TY  - JOUR
TI  - Understanding public perspectives on direct-to-consumer pharmacogenomic testing in the UK: a qualitative study.
AU  - Mathieson A
AU  - Brunton L
AU  - Gillibrand S
AU  - Moldovan R
AU  - McDermott JH
PY  - 2026
JO  - The pharmacogenomics journal
DO  - 10.1038/s41397-026-00425-1
UR  - https://doi.org/10.1038/s41397-026-00425-1
ER  - 

APA

A, M., L, B., S, G., R, M., & JH, M. (2026). Understanding public perspectives on direct-to-consumer pharmacogenomic testing in the UK: a qualitative study.. The pharmacogenomics journal. https://doi.org/10.1038/s41397-026-00425-1

Source records